Nobel Biocare implements new holding structure:
This article was originally published in Clinica
Swedish dental implants company Nobel Biocare (Gothenburg) will set up a new Swiss holding structure, which, it says, will enhance its competitive position and give it access to wider capital markets. The new Swiss parent will be listed in Zurich and in Stockholm. The transaction will be effected via a share swap, with shareholders gaining one new share in Nobel Biocare AG for each existing share in Nobel Biocare AB. The latter will become a subsidiary of the new parent under the new structure. No changes in board composition are expected.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.